CNTN (Canton Strategic Holdings) Market Cap: $175.07 Mil (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNTN Canton Strategic Holdings Inc CNTN
26 GF Score
Price $2.27
! 2 Warning Signs
View Full Analysis

What is Canton Strategic Holdings Market Cap?

Canton Strategic Holdings CNTN -5.02% 26 Market Cap is $175.07 Mil as of Jul. 13, 2026. GuruFocus rates CNTN with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,423 Biotechnology companies, Canton Strategic Holdings ranks better than 56.08% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Canton Strategic Holdings's share price for the quarter that ended in Mar. 2026 was $3.27. Canton Strategic Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 56.66 Mil. Therefore, Canton Strategic Holdings's market cap for the quarter that ended in Mar. 2026 was $185.27 Mil.

Canton Strategic Holdings's quarterly market cap increased from Sep. 2025 ($20.47 Mil) to Dec. 2025 ($112.45 Mil) and increased from Dec. 2025 ($112.45 Mil) to Mar. 2026 ($185.27 Mil).

Canton Strategic Holdings's annual market cap declined from Dec. 2023 ($5.98 Mil) to Dec. 2024 ($4.01 Mil) but then increased from Dec. 2024 ($4.01 Mil) to Dec. 2025 ($112.45 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Canton Strategic Holdings's Enterprise Value for Today is $167.63 Mil.


Canton Strategic Holdings  (NAS:CNTN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Canton Strategic Holdings Market Cap Related Terms


Canton Strategic Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Canton Strategic Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canton Strategic Holdings Market Cap Chart

Canton Strategic Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 0.00 4.53 5.98 4.01 112.45

Canton Strategic Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 8.19 20.47 112.45 185.27

CNTN vs RNA, TARA, CHRS: Market Cap Comparison

For the Biotechnology subindustry, Canton Strategic Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canton Strategic Holdings Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Canton Strategic Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Canton Strategic Holdings's Market Cap falls into.


CNTN
26GF Score
Canton Strategic Holdings Inc CNTN
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canton Strategic Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Canton Strategic Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=$3.03*37.112
=$112.45

Canton Strategic Holdings's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=$3.27*56.656
=$185.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $175.07 Mil mean?
Canton Strategic Holdings (CNTN) has a Market Cap of $175.07 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Canton Strategic Holdings and its competitors. According to the industry distribution chart, Canton Strategic Holdings ranks #625 out of 1423 companies in the Biotechnology industry, placing it in the top 43.9%.
Is Canton Strategic Holdings' Market Cap too high?
Canton Strategic Holdings' current Market Cap is $175.07 Mil. The Biotechnology industry median Market Cap is 119.31. Canton Strategic Holdings' value of $175.07 Mil is 46.7% above this industry median. Based on the distribution chart, Canton Strategic Holdings ranks #625 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Canton Strategic Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Canton Strategic Holdings' Market Cap compare to RNA and TARA?
According to the Biotechnology industry distribution chart, Canton Strategic Holdings ranks #625 out of 1423 companies for Market Cap. This puts Canton Strategic Holdings in the upper half of its industry. The industry median Market Cap is 119.31. Canton Strategic Holdings' value of $175.07 Mil is 46.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.31, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Canton Strategic Holdings's current Market Cap of $175.07 Mil is 46.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Canton Strategic Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 119.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Canton Strategic Holdings's current Market Cap is $175.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canton Strategic Holdings stock overvalued right now?
Canton Strategic Holdings (CNTN) has a current Market Cap of $175.07 Mil. The current Market Cap is $175.07 Mil and 46.7% above the Biotechnology industry median of 119.31. Canton Strategic Holdings' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Canton Strategic Holdings (CNTN), the current Market Cap is $175.07 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Canton Strategic Holdings Business Description

Address 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ, USA, 07701
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
26GF Score

Get the complete analysis for CNTN

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.27
Price